A Study to Learn How Safe the Study Drug Intravitreal (Given by an Injection Into the Eye) Aflibercept is in Participants in India With Diabetic Macular Edema

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 26, 2022

Primary Completion Date

April 16, 2024

Study Completion Date

April 16, 2024

Conditions
Diabetic Macular Edema
Interventions
DRUG

Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)

Injection, 2mg (equivalent to 50 µL solution for injection)

Trial Locations (10)

110029

Dr. R.P. Centre for Ophthalmic Sciences, AIIMS, New Delhi

160012

Post Graduate Institute of Medical Education and Research, Chandigarh

380016

M & J Western Regional Institute of Ophthalmology, Ahmedabad

380052

Raghudeep Eye Hospital, Ahmedabad

500034

L.V. Prasad Eye Institute, Hyderabad

560010

Narayana Nethralaya, Bengaluru

560037

Sankara Eye Hospital, Bengaluru

600006

Medical Research Foundation, Sankara Nethralaya, Chennai

641014

Lotus Eye Hospital and Institute, Coimbatore

700120

Disha Eye Hospitals, Kolkata

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY